28077289|t|Vitamin D3 protects against Aβ peptide cytotoxicity in differentiated human neuroblastoma SH- SY5Y cells: A role for S1P1 / p38MAPK / ATF4 axis
28077289|a|Besides its classical function of bone metabolism regulation, 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3), acts on a variety of tissues including the nervous system, where the hormone plays an important role as neuroprotective, antiproliferating and differentiating agent. Sphingolipids are bioactive lipids that play critical and complex roles in regulating cell fate. In the present paper we have investigated whether sphingolipids are involved in the protective action of 1,25(OH)2D3. We have found that 1,25(OH)2D3 prevents amyloid-β peptide (Aβ(1-42)) cytotoxicity both in differentiated SH-SY5Y human neuroblastoma cells and in vivo. In differentiated SH-SY5Y cells, Aβ(1-42) strongly reduces the sphingosine-1-phosphate (S1P)/ ceramide (Cer) ratio while 1,25(OH)2D3 partially reverts this effect. 1,25(OH)2D3 reverts also the Aβ(1-42) - induced reduction of sphingosine kinase activity. We have also studied the crosstalk between 1,25(OH)2D3 and S1P signaling pathways downstream to the activation of S1P receptor subtype S1P1. Notably, we found that 1,25(OH)2D3 prevents the reduction of S1P1 expression promoted by Aβ(1-42) and thereby it modulates the downstream signaling leading to ER stress damage (p38MAPK / ATF4). Similar effects were observed by using ZK191784. In addition, chronic treatment with 1,25(OH)2D3 protects from aggregated Aβ(1-42) - induced damage in the CA1 region of the rat hippocampus and promotes cell proliferation in the hippocampal dentate gyrus of adult mice. In conclusion, these results represent the first evidence of the role of 1,25(OH)2D3 and its structural analogue ZK191784 in counteracting the Aβ(1-42) peptide - induced toxicity through the modulation of S1P/S1P1/p38MAPK/ATF4 pathway in differentiated SH-SY5Y cells.
28077289	0	10	Vitamin D3	T109,T121,T127	C0006674
28077289	28	38	Aβ peptide	T116	C0078939
28077289	39	51	cytotoxicity	T049	C0596402
28077289	70	75	human	T016	C0086418
28077289	76	89	neuroblastoma	T191	C0027819
28077289	90	104	SH- SY5Y cells	T025	C0007634
28077289	117	121	S1P1	T116,T192	C3537343
28077289	124	131	p38MAPK	T116,T126	C1120843
28077289	134	138	ATF4	T116,T123	C0101379
28077289	178	182	bone	T023	C0262950
28077289	183	204	metabolism regulation	T040	C1159402
28077289	206	236	1alpha, 25-dihydroxyvitamin D3	T109,T121,T127	C0006674
28077289	238	249	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	273	280	tissues	T024	C0040300
28077289	295	309	nervous system	T022	C0027763
28077289	321	328	hormone	T125	C0019932
28077289	356	371	neuroprotective	T121	C0242912
28077289	373	390	antiproliferating	T109,T121	C0003392
28077289	395	416	differentiating agent	T120	C1511939
28077289	418	431	Sphingolipids	T109	C0037900
28077289	436	452	bioactive lipids	T123	C0574031
28077289	493	513	regulating cell fate	T038	C1327622
28077289	544	556	investigated	T169	C1292732
28077289	565	578	sphingolipids	T109	C0037900
28077289	599	616	protective action	T033	C1545588
28077289	620	631	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	652	663	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	673	690	amyloid-β peptide	T116	C0078939
28077289	692	700	Aβ(1-42)	T116	C0078939
28077289	702	714	cytotoxicity	T049	C0596402
28077289	738	771	SH-SY5Y human neuroblastoma cells	UnknownType	C0815000
28077289	776	783	in vivo	T082	C1515655
28077289	788	816	differentiated SH-SY5Y cells	T025	C0007634
28077289	818	826	Aβ(1-42)	T116	C0078939
28077289	848	871	sphingosine-1-phosphate	T109	C0074992
28077289	873	876	S1P	T109	C0074992
28077289	879	887	ceramide	T109,T123	C0007745
28077289	889	892	Cer	T109,T123	C0007745
28077289	894	899	ratio	T081	C0456603
28077289	906	917	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	949	960	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	978	986	Aβ(1-42)	T116	C0078939
28077289	989	996	induced	T169	C0205263
28077289	997	1006	reduction	T080	C0392756
28077289	1010	1037	sphingosine kinase activity	T044	C1150463
28077289	1082	1093	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	1098	1120	S1P signaling pathways	T044	C2984468
28077289	1139	1149	activation	T043	C1514758
28077289	1153	1178	S1P receptor subtype S1P1	T116,T192	C0390526
28077289	1203	1214	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	1228	1237	reduction	T080	C0392756
28077289	1241	1245	S1P1	T116,T192	C0390526
28077289	1246	1256	expression	T045	C0597360
28077289	1269	1277	Aβ(1-42)	T116	C0078939
28077289	1293	1302	modulates	UnknownType	C0678672
28077289	1307	1327	downstream signaling	T038	C3537152
28077289	1339	1355	ER stress damage	T049	C3178870
28077289	1357	1364	p38MAPK	T116,T126	C1120843
28077289	1367	1371	ATF4	T116,T123	C0101379
28077289	1413	1421	ZK191784	T127	C1173774
28077289	1436	1453	chronic treatment	T061	C0087111
28077289	1459	1470	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	1496	1504	Aβ(1-42)	T116	C0078939
28077289	1507	1514	induced	T169	C0205263
28077289	1515	1521	damage	T037	C0010957
28077289	1529	1539	CA1 region	T029	C0694598
28077289	1547	1550	rat	T015	C0086893
28077289	1551	1562	hippocampus	T023	C0019564
28077289	1576	1594	cell proliferation	T043	C0596290
28077289	1602	1627	hippocampal dentate gyrus	T023	C0152314
28077289	1631	1636	adult	T100	C0001675
28077289	1637	1641	mice	T015	C0025929
28077289	1664	1671	results	T169	C1274040
28077289	1692	1700	evidence	T078	C3887511
28077289	1716	1727	1,25(OH)2D3	T109,T121,T127	C0006674
28077289	1736	1755	structural analogue	T104	C0243071
28077289	1756	1764	ZK191784	T127	C1173774
28077289	1786	1802	Aβ(1-42) peptide	T116	C0078939
28077289	1805	1812	induced	T169	C0205263
28077289	1813	1821	toxicity	T037	C0600688
28077289	1834	1844	modulation	UnknownType	C0678672
28077289	1848	1877	S1P/S1P1/p38MAPK/ATF4 pathway	T044	C0037080
28077289	1896	1909	SH-SY5Y cells	T025	C0007634